powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1134410277
Ali Naboush
M.D
Hematology-Oncology
Bayside,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 330182
Hospital
CCN 330195
Hospital
CCN 330214
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
324
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
11
Brand share
78.7%
Top prescribed drugs
Darbepoetin Alfa In Polysorbat
75 claims
Apixaban
63 claims
Lenalidomide
41 claims
Denosumab
32 claims
Acyclovir
23 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
15.8
Cost
75.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,311
Unique beneficiaries
—
Total services
28,655
Distinct HCPCS
47
Medicare payment
$312K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 628 Hematology-Oncology providers in NY — top quintile (cohort median 883).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.